Evoz Pharmaceutical Private Limited
About Evoz Pharmaceutical Private Limited
Data last updated:
Evoz Pharmaceutical Private Limited is a private limited company based in Kalamboli, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC291027.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rashmi Dwivedi (Managing Director) and Mithlesh Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat C/101 Pl – 22 Sec – 11 E.V Regency Panvel Mumbai, Kalamboli, Maharashtra, India – 401208.
As per the financials filed for FY 2024, the company reported a revenue of ₹34.07 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹3,876 (net margin 0.1%) and EBITDA of ₹11,657 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat C/101 Pl – 22 Sec – 11 E.V Regency Panvel Mumbai, Kalamboli, Maharashtra, India – 401208
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Evoz Pharmaceutical Private Limited
The main business activity of Evoz Pharmaceutical is financial and insurance activities. In detail, this covers activities auxiliary to financial service and insurance activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| K | Financial and insurance activities | 66 | Activities auxiliary to financial service and insurance activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Evoz Pharmaceutical Private Limited FY 2024 filings available
Evoz Pharmaceutical Private Limited reported revenue of ₹34.07 Lakh (up 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Evoz Pharmaceutical Private Limited
Revenue rose 35% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 16%. EBITDA rose 201% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Evoz Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11,657 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,876 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Evoz Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Evoz Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Evoz Pharmaceutical Private Limited
Evoz Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Activities auxiliary to financial service and insurance activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dodda Basavanagudi Chits Private Limited | ₹34.2 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Bangalore, Karnataka, India |
| Credifiers Services (OPC) Private Limited | ₹34.2 Lakh (FY 2025) | •••• | •••• | 146.0% | •••• | Noida, Uttar Pradesh, India |
| Knop Trading Co. Pvt.Ltd. | ₹34.15 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Khandare Brother's Multipurpose (OPC) Private Limited | ₹34.15 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Pune, Maharashtra, India |
| Arcis Trade Private Limited | ₹34.13 Lakh (FY 2023) | •••• | •••• | -62.0% | •••• | Mumbai, Maharashtra, India |
| Evoz Pharmaceutical Private Limited this company | ₹34.07 Lakh (FY 2024) | •••• | •••• | 35.0% | •••• | Kalamboli, Maharashtra, India |
| Bloomingdale Investments Private Limited | ₹34.06 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Easyfin Financial Services Private Limited | ₹34.05 Lakh (FY 2025) | •••• | •••• | 60.0% | •••• | Mumbai, Maharashtra, India |
| Hemdev Corporate Services Private Limited | ₹34.03 Lakh (FY 2025) | •••• | •••• | 45.0% | •••• | Mumbai, Maharashtra, India |
| Geecee Business Private Limited | ₹34.02 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| Faering Capital Trustee Company Private Limited | ₹34.01 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Evoz Pharmaceutical by revenue in the same principal business activity (Activities auxiliary to financial service and insurance activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Evoz Pharmaceutical Private Limited
Evoz Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mithlesh Dwivedi | Director | 10 Feb 2017 | 9 Years 8 Months | Current |
| Rashmi Dwivedi | Managing Director | 10 Feb 2017 | 9 Years 8 Months | Current |
Charges & Borrowings of Evoz Pharmaceutical Private Limited
Evoz Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Evoz Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Evoz Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Evoz Pharmaceutical Private Limited
Evoz Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Mithlesh Dwivedi was appointed as Director on 10 Feb 2017.
Credit Ratings, Litigation & Regulatory Alerts for Evoz Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Evoz Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Evoz Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Evoz Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Evoz Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evoz Pharmaceutical Private Limited
Evoz Pharmaceutical is an active private limited company based in Kalamboli, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 February 2017 (9+ years old) and is registered under CIN U74999MH2017PTC291027.
Evoz Pharmaceutical reported revenue of ₹34.07 Lakh for FY 2024 (up 35% YoY).
Evoz Pharmaceutical has 2 current directors:
- Rashmi Dwivedi - Managing Director
- Mithlesh Dwivedi - Director
Evoz Pharmaceutical reported a net profit of ₹3,876 (net margin 0.1%) and EBITDA of ₹11,657 (EBITDA margin 0.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Evoz Pharmaceutical is 40% over three years and -16% over five years. In the latest year (FY 2024) revenue rose 35%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Evoz Pharmaceutical is U74999MH2017PTC291027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evoz Pharmaceutical was incorporated on 10 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Evoz Pharmaceutical by revenue are Dodda Basavanagudi Chits Private Limited, Credifiers Services (OPC) Private Limited, Knop Trading Co. Pvt.Ltd, Khandare Brother's Multipurpose (OPC) Private Limited, Arcis Trade Private Limited and 5 more, all in the same principal business activity (Activities auxiliary to financial service and insurance activities).
Mithlesh Dwivedi was appointed as Director on 10 Feb 2017. Rashmi Dwivedi was appointed as Managing Director on 10 Feb 2017.
The registered office of Evoz Pharmaceutical is at Flat C101 Pl – 22 Sec – 11 E.V Regency Panvel Mumbai, Kalamboli, Maharashtra, India – 401208.
Evoz Pharmaceutical has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.